NIH-funded research R01 grant

How reproductive and biological aging affect women's health and diabetes risk

Official title: The interplay among reproductive, molecular, and chronological age in relation to aging-related conditions in women: a longitudinal study

Funded at Harvard Pilgrim Health Care, INC. · NIH-11388748 · Data updated 2026-11-12

This project will look at how reproductive milestones (like age at menopause), biological aging markers from blood, and actual age relate to diabetes and other aging-related conditions in women.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard Pilgrim Health Care, INC.
NIH-funded
Lab location1 site (Canton, UNITED STATES)
Project startMay 1, 2026
Project endFebruary 28, 2031
Funding year2026
Award (this year)$706,310
NIH project number1R01AG101869-01
Project IDNIH-11388748 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adult women with documented reproductive history (for example, age at menarche and menopause) and medical records or blood samples that can be linked over time.

Less likely to help

Women who lack reproductive history or linked medical/lab records are unlikely to see direct benefits from participating.

What this research studies

If you join, researchers will use existing long-term health records and lab data from women to compare menstrual and menopause history, blood-based markers of biological aging, and calendar age to see which best predicts diabetes and other age-related problems. They will follow medical records, lab results, and measures of thinking and physical function over time to track how these factors change. The team will pay close attention to menopause timing and common risk factors such as obesity, smoking, high blood pressure, and diabetes. Advanced statistical methods will be used to separate the effects of reproductive aging and molecular aging from simply getting older.

Why it matters

Potential benefit: If successful, the project could help spot women at higher risk for diabetes and other aging conditions earlier so care can be better personalized and prevention targeted.

How similar studies have gone: Previous population studies have tied menopause timing and biological aging markers to heart disease and dementia, but combining reproductive, molecular, and chronological measures in women is relatively new.

Where this research is happening

  • Harvard Pilgrim Health Care, INC.
    Canton, United States
    Active

Researchers

  • Principal investigator: Oken, Emily — Harvard Pilgrim Health Care, INC.
  • Study coordinator: Oken, Emily

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.